To assess the efficacy and safety of OTX-DED for the short-term treatment of the symptoms of DED
Randomized, double-masked, study to evaluate the efficacy and safety of OTX-DED (dexamethasone intracanalicular ophthalmic insert) for the short-term treatment of the symptoms of dry eye disease (DED). The subjects will be followed for approximately two months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
100
0.3mg dexamethasone ophthalmic insert
Collagen Punctal Plug 0.2mm (Controlled Insertion)
Collagen Punctal Plug 0.2mm (Full Insertion)
Ocular Therapeutix
Memphis, Tennessee, United States
Severity of Eye Dryness Score (visual analogue scale (VAS))
Visual Analogue Scale (0 mm - no discomfort to 100mm - maximal (the most) discomfort)
Time frame: Change from baseline (CFB) at Day 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.